All Pharma News
Synairgen announces data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001

Synairgen announces data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001
BUSINESSWIRE
04 Oct 2022
Share Share
Synairgen assessing three clinical options for antiviral drug

Synairgen assessing three clinical options for antiviral drug
PROACTIVEINVESTOR
29 Sep 2022
Share Share
Synairgen to Present COVID Data From Phase 3 SPRINTER Study

Synairgen to Present COVID Data From Phase 3 SPRINTER Study
BUSINESSWIRE
20 Sep 2022
Share Share
Synairgen announces positive findings from the SG015 trial of SNG001

Synairgen announces positive findings from the SG015 trial of SNG001
BUSINESSWIRE
07 Sep 2022
Share Share
Synairgen announces its collaboration the UNIVERSAL trial, an study of patients

Synairgen announces its collaboration the UNIVERSAL trial, an study of patients
SYNAIRGEN
05 Sep 2022
Share Share
Synairgen tests new anti-Covid drug

Synairgen tests new anti-Covid drug
Chris Yandall DAILY ECHO
16 May 2022
Share Share
Synairgen to present at ATS 2022

Synairgen to present at ATS 2022
PRESS RELEASE
05 Apr 2022
Share Share
Synairgen ACTIV-2 trial paused while NIH tweaks study design

Synairgen ACTIV-2 trial paused while NIH tweaks study design
Max Bayer FIERCEBIOTECH
05 Mar 2022
Share Share
Synairgen halts Phase III trial of SNG001 for Covid-19 treatment

Synairgen halts Phase III trial of SNG001 for Covid-19 treatment
CLINICALTRIALSARENA
04 Mar 2022
Share Share
Biotech shares eviscerated in wake of Covid-19 flop

Biotech shares eviscerated in wake of Covid-19 flop
Amber Tong ENDPTS
22 Feb 2022
Share Share